文献速递免疫规划卫生政策与健康促进

美国不同类型医护人员的新冠疫苗接种情况

COVID-19 vaccination among different types of US Healthcare Personnel.
PubMed 文献 · Vaccine · 2023-01-20

2021年9月通过双重选择加入网络小组对美国医护人员开展调查,共1074人,超过94%报告已接种至少一剂新冠疫苗或近期打算接种;对CDC信任度高者接种比值比为26(95%CI:9,74);近半数未接种者担心副作用。

要点

  • 1074名受访医护人员中超过94%已接种至少一剂新冠疫苗或打算近期接种。
  • 对CDC高信任度医护人员接种的比值比为26(95%CI:9,74)。
  • 未接种者中47%担心副作用,33%担心疫苗研发过快。

核心结论

  • 多数医护人员已接种新冠疫苗并向患者强烈推荐接种,但部分人持有与公众类似的担忧。
  • 需要定期更新的额外资源来解释不断发展的科学进展并回应公众关切,以进一步提高医护人员疫苗覆盖率并帮助其支持患者决策。

研究设计与样本

  • 于2021年9月通过双重选择加入网络小组对医护人员开展调查,共纳入1074名医护人员。
  • 调查结果按医护人员类型分层汇总,并拟合调整后的逻辑回归模型。

主要发现

  • 1074名受访医护人员中超过94%报告已接种至少一剂新冠疫苗或打算近期接种。
  • 接种最常见于儿科医生(98%),其次为家庭医学医生(96%)、药师(94%)和护士/执业护士/医师助理(88%)。
  • 对CDC高信任度的医护人员接种的比值比为26(95%CI:9,74),对照为低信任度者。
  • 未接种医护人员中近半数(47%)担心副作用,三分之一(33%)担心疫苗研发过快。
  • 约四分之三医护人员报告向患者强烈推荐辉瑞-BioNTech(75%)和莫德纳(70%)疫苗,约四分之一(24%)强烈推荐强生疫苗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing vaccine coverage remains the best way to control the COVID-19 pandemic. Healthcare personnel (HCP) have long been the most credible and frequently used source of vaccine information for the public, and an HCP recommendation is a strong predictor of vaccination. METHODS: A survey of HCP was conducted in September 2021 via a double opt-in network panel. Responses to survey items were summarized and stratified by HCP type and adjusted logistic regression models were fitted. RESULTS: >94% of the 1074 HCP surveyed reported receiving at least one dose of COVID-19 vaccine or intending to soon, with vaccinating most common among pediatricians (98%), followed by family medicine doctors (96%), pharmacists (94%), and nurses/nurse practitioners/physician assistants (88%). HCP with high trust in the Centers for Disease Control and Prevention had 26 times the odds of vaccinating of HCP with low trust (95%CI: 9, 74). Nearly half of unvaccinated HCP (47%) were concerned about side effects, and one third of unvaccinated HCP (33%) were concerned the vaccine was developed too quickly. About three quarters of HCP reported strongly recommending the Pfizer-BioNTech (75%) and Moderna (70%) vaccines to their patients, compared to about one quarter (24%) strongly recommending Johnson & Johnson. CONCLUSIONS: Although most HCP are vaccinated against COVID-19 and strongly recommend vaccination to their patients, some harbor similar concerns to the public. Additional resources - regularly updated to explain the progressing scientific landscape and address ever evolving public concerns - are needed to further improve vaccine coverage among HCP and aid them in supporting the decision-making of their patients.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dudley MZ, Schuh HB, Shaw J, et al. COVID-19 vaccination among different types of US Healthcare Personnel. Vaccine. 2023. PMID: 36707335. doi:10.1016/j.vaccine.2023.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。